Equity - Schedule of Company Share Purchase Warrants Outstanding (Details) - Warrants [member]
|
12 Months Ended |
|
Mar. 31, 2025
USD ($)
$ / shares
shares
|
|---|
| Schedule of Company Share Purchase Warrants Outstanding [Line Items] |
|
| Number of warrants outstanding, Balance |
32,900,000
|
| Termination | shares |
(14,000,000)
|
| Number of warrants outstanding, Balance |
18,900,000
|
| Fair value at issue date |
$ 24,379,389
|
| Fair value charged for current year |
$ 1,680,038,000,000
|
| October 29, 2031 [Member] |
|
| Schedule of Company Share Purchase Warrants Outstanding [Line Items] |
|
| Number of warrants outstanding, Balance |
3,500,000
|
| Termination | shares |
(3,500,000)
|
| Number of warrants outstanding, Balance |
|
| Fair value at issue date |
$ 4,515,601
|
| Fair value charged for current year |
|
| Exercise price | $ / shares |
$ 1
|
| Weighted average remaining life |
|
| October 29, 2031 [Member] |
|
| Schedule of Company Share Purchase Warrants Outstanding [Line Items] |
|
| Number of warrants outstanding, Balance |
3,500,000
|
| Termination | shares |
(3,500,000)
|
| Number of warrants outstanding, Balance |
|
| Fair value at issue date |
$ 4,229,191
|
| Fair value charged for current year |
|
| Exercise price | $ / shares |
$ 1.5
|
| Weighted average remaining life |
|
| October 29, 2031 [Member] |
|
| Schedule of Company Share Purchase Warrants Outstanding [Line Items] |
|
| Number of warrants outstanding, Balance |
7,000,000
|
| Termination | shares |
(7,000,000)
|
| Number of warrants outstanding, Balance |
|
| Fair value at issue date |
$ 7,500,124
|
| Fair value charged for current year |
$ 1,323,807,000,000
|
| Exercise price | $ / shares |
$ 2.5
|
| Weighted average remaining life |
|
| October 27, 2026 [Member] |
|
| Schedule of Company Share Purchase Warrants Outstanding [Line Items] |
|
| Number of warrants outstanding, Balance |
1,800,000
|
| Termination | shares |
|
| Number of warrants outstanding, Balance |
1,800,000
|
| Fair value at issue date |
$ 1,353,304
|
| Fair value charged for current year |
|
| Exercise price | $ / shares |
$ 1.5
|
| Weighted average remaining life |
2 years
|
| October 29, 2026 [Member] |
|
| Schedule of Company Share Purchase Warrants Outstanding [Line Items] |
|
| Number of warrants outstanding, Balance |
2,000,000
|
| Termination | shares |
|
| Number of warrants outstanding, Balance |
2,000,000
|
| Fair value at issue date |
$ 1,417,766
|
| Fair value charged for current year |
|
| Exercise price | $ / shares |
$ 1.5
|
| Weighted average remaining life |
2 years
|
| May 10, 2027 [Member] |
|
| Schedule of Company Share Purchase Warrants Outstanding [Line Items] |
|
| Number of warrants outstanding, Balance |
200,000
|
| Termination | shares |
|
| Number of warrants outstanding, Balance |
200,000
|
| Fair value at issue date |
$ 84,000
|
| Fair value charged for current year |
|
| Exercise price | $ / shares |
$ 1.5
|
| Weighted average remaining life |
3 years
|
| May 26, 2027 [Member] |
|
| Schedule of Company Share Purchase Warrants Outstanding [Line Items] |
|
| Number of warrants outstanding, Balance |
500,000
|
| Termination | shares |
|
| Number of warrants outstanding, Balance |
500,000
|
| Fair value at issue date |
$ 238,000
|
| Fair value charged for current year |
|
| Exercise price | $ / shares |
$ 1.5
|
| Weighted average remaining life |
3 years
|
| July 22, 2027 [Member] |
|
| Schedule of Company Share Purchase Warrants Outstanding [Line Items] |
|
| Number of warrants outstanding, Balance |
440,000
|
| Termination | shares |
|
| Number of warrants outstanding, Balance |
440,000
|
| Fair value at issue date |
$ 163,000
|
| Fair value charged for current year |
$ 7,555,000,000
|
| Exercise price | $ / shares |
$ 1
|
| Weighted average remaining life |
3 years
|
| July 25, 2027 [Member] |
|
| Schedule of Company Share Purchase Warrants Outstanding [Line Items] |
|
| Number of warrants outstanding, Balance |
3,780,000
|
| Termination | shares |
|
| Number of warrants outstanding, Balance |
3,780,000
|
| Fair value at issue date |
$ 1,405,000
|
| Fair value charged for current year |
$ 65,398,000,000
|
| Exercise price | $ / shares |
$ 1
|
| Weighted average remaining life |
3 years
|
| July 26, 2027 [Member] |
|
| Schedule of Company Share Purchase Warrants Outstanding [Line Items] |
|
| Number of warrants outstanding, Balance |
400,000
|
| Termination | shares |
|
| Number of warrants outstanding, Balance |
400,000
|
| Fair value at issue date |
$ 146,000
|
| Fair value charged for current year |
$ 6,806,000,000
|
| Exercise price | $ / shares |
$ 1
|
| Weighted average remaining life |
3 years
|
| July 27, 2027 [Member] |
|
| Schedule of Company Share Purchase Warrants Outstanding [Line Items] |
|
| Number of warrants outstanding, Balance |
1,000,000
|
| Termination | shares |
|
| Number of warrants outstanding, Balance |
1,000,000
|
| Fair value at issue date |
$ 379,000
|
| Fair value charged for current year |
$ 17,691,000,000
|
| Exercise price | $ / shares |
$ 1
|
| Weighted average remaining life |
3 years
|
| July 28, 2027 [Member] |
|
| Schedule of Company Share Purchase Warrants Outstanding [Line Items] |
|
| Number of warrants outstanding, Balance |
980,000
|
| Termination | shares |
|
| Number of warrants outstanding, Balance |
980,000
|
| Fair value at issue date |
$ 376,000
|
| Fair value charged for current year |
$ 17,575,000,000
|
| Exercise price | $ / shares |
$ 1
|
| Weighted average remaining life |
3 years
|
| November 28, 2027 [Member] |
|
| Schedule of Company Share Purchase Warrants Outstanding [Line Items] |
|
| Number of warrants outstanding, Balance |
1,125,000
|
| Termination | shares |
|
| Number of warrants outstanding, Balance |
1,125,000
|
| Fair value at issue date |
$ 264,000
|
| Fair value charged for current year |
|
| Exercise price | $ / shares |
$ 1
|
| Weighted average remaining life |
3 years
|
| November 28, 2027 [Member] |
|
| Schedule of Company Share Purchase Warrants Outstanding [Line Items] |
|
| Number of warrants outstanding, Balance |
1,125,000
|
| Termination | shares |
|
| Number of warrants outstanding, Balance |
1,125,000
|
| Fair value at issue date |
$ 274,000
|
| Fair value charged for current year |
|
| Exercise price | $ / shares |
$ 1
|
| Weighted average remaining life |
3 years
|
| November 28, 2027 [Member] |
|
| Schedule of Company Share Purchase Warrants Outstanding [Line Items] |
|
| Number of warrants outstanding, Balance |
1,125,000
|
| Termination | shares |
|
| Number of warrants outstanding, Balance |
1,125,000
|
| Fair value at issue date |
$ 289,000
|
| Fair value charged for current year |
$ 29,695,000,000
|
| Exercise price | $ / shares |
$ 1
|
| Weighted average remaining life |
3 years
|
| November 28, 2027 [Member] |
|
| Schedule of Company Share Purchase Warrants Outstanding [Line Items] |
|
| Number of warrants outstanding, Balance |
1,125,000
|
| Termination | shares |
|
| Number of warrants outstanding, Balance |
1,125,000
|
| Fair value at issue date |
$ 303,000
|
| Fair value charged for current year |
$ 100,032,000,000
|
| Exercise price | $ / shares |
$ 1
|
| Weighted average remaining life |
3 years
|
| November 28, 2032 [Member] |
|
| Schedule of Company Share Purchase Warrants Outstanding [Line Items] |
|
| Number of warrants outstanding, Balance |
750,000
|
| Termination | shares |
|
| Number of warrants outstanding, Balance |
750,000
|
| Fair value at issue date |
$ 263,000
|
| Fair value charged for current year |
|
| Exercise price | $ / shares |
$ 1.5
|
| Weighted average remaining life |
8 years
|
| November 28, 2032 [Member] |
|
| Schedule of Company Share Purchase Warrants Outstanding [Line Items] |
|
| Number of warrants outstanding, Balance |
250,000
|
| Termination | shares |
|
| Number of warrants outstanding, Balance |
250,000
|
| Fair value at issue date |
$ 89,000
|
| Fair value charged for current year |
|
| Exercise price | $ / shares |
$ 1.5
|
| Weighted average remaining life |
8 years
|
| November 28, 2032 [Member] |
|
| Schedule of Company Share Purchase Warrants Outstanding [Line Items] |
|
| Number of warrants outstanding, Balance |
500,000
|
| Termination | shares |
|
| Number of warrants outstanding, Balance |
500,000
|
| Fair value at issue date |
$ 165,000
|
| Fair value charged for current year |
|
| Exercise price | $ / shares |
$ 2.5
|
| Weighted average remaining life |
8 years
|
| November 28, 2032 [Member] |
|
| Schedule of Company Share Purchase Warrants Outstanding [Line Items] |
|
| Number of warrants outstanding, Balance |
500,000
|
| Termination | shares |
|
| Number of warrants outstanding, Balance |
500,000
|
| Fair value at issue date |
$ 169,000
|
| Fair value charged for current year |
$ 17,365,000,000
|
| Exercise price | $ / shares |
$ 2.5
|
| Weighted average remaining life |
8 years
|
| November 28, 2032 [Member] |
|
| Schedule of Company Share Purchase Warrants Outstanding [Line Items] |
|
| Number of warrants outstanding, Balance |
250,000
|
| Termination | shares |
|
| Number of warrants outstanding, Balance |
250,000
|
| Fair value at issue date |
$ 87,000
|
| Fair value charged for current year |
$ 8,939,000,000
|
| Exercise price | $ / shares |
$ 6
|
| Weighted average remaining life |
8 years
|
| November 28, 2032 [Member] |
|
| Schedule of Company Share Purchase Warrants Outstanding [Line Items] |
|
| Number of warrants outstanding, Balance |
750,000
|
| Termination | shares |
|
| Number of warrants outstanding, Balance |
750,000
|
| Fair value at issue date |
$ 258,000
|
| Fair value charged for current year |
$ 85,175,000,000
|
| Exercise price | $ / shares |
$ 6
|
| Weighted average remaining life |
8 years
|
| December 23, 2028 [Member] |
|
| Schedule of Company Share Purchase Warrants Outstanding [Line Items] |
|
| Number of warrants outstanding, Balance |
300,000
|
| Termination | shares |
|
| Number of warrants outstanding, Balance |
300,000
|
| Fair value at issue date |
$ 411,403
|
| Fair value charged for current year |
|
| Exercise price | $ / shares |
$ 1
|
| Weighted average remaining life |
3 years
|